scorecard

You Searched For "remdesivir drug cost" and got 16 results


Sort By:


Business Insider Latest Story Image
2 mins read

These are the companies that are making Remdesivir in India

Zydus Cadila has launched Remdesivir under the brand name Remdac, used to treat patients sufferin…

Business Insider Latest Story Image
5 mins read

Remdesivir drug fails to reduce mortality or hospital stay of COVID-19 patients, says WHO study

Remdesivir, one of the earliest touted treatments for COVID-19 in the world, is not effective in pr…

Business Insider Latest Story Image
2 mins read

Cipla to sell anti-viral drug remdesivir as Cipremi in India

In May, US drug maker Gilead Sciences extended a voluntary non-exclusive license to Cipla to man…

Business Insider Latest Story Image
4 mins read

Remdesivir, the only FDA-authorized drug for COVID-19, may not significantly improve outcomes, a study found

Remdesivir is the only drug authorized by the FDA to treat the coronavirus. But a new study shows i…

Susie Neilson   


Business Insider Latest Story Image
6 mins read

Dispensed: A week of drug developments, the plan to restart hospitals, and some non-coronavirus news

Welcome to Dispensed, BI's weekly healthcare newsletter. This week, the TLDR on remdesivir, a promi…

Lydia Ramsey   


Business Insider Latest Story Image
1 min read

Cipla to price generic version of COVID-19 drug remdesivir at less than Rs 5,000 per vial

Cipla has been granted regulatory approval by the Drug Controller General of India (DCGI) for rest…

PTI   


Business Insider Latest Story Image
6 mins read

The 'most promising' coronavirus treatment faces its biggest test yet. Clinical data for Gilead's drug remdesivir is coming in a matter of weeks.

In that account, the patient who was the first confirmed case of COVID-19 in the US received remdes…

Andrew Dunn   


Business Insider Latest Story Image
5 mins read

While coronavirus vaccines race ahead, our treatment options remain mediocre. There are good reasons for that.

Coronavirus vaccines like Pfizer's and Moderna's have exceeded expectations, while treatments like …

Susie Neilson   


Business Insider Latest Story Image
3 mins read

The WHO will not recommend remdesivir for COVID-19 patients, since it doesn't seem to boost their chances of survival

In a statement on Thursday, the World Health Organization said it will not recommend remdesivir bec…

Susie Neilson   


Business Insider Latest Story Image
6 mins read

A spate of advancements suggest new coronavirus treatments could be on the horizon — here's the latest

Potential therapies from pharma giant Eli Lilly and biotech company Regeneron saw promising trial r…

Aria Bendix   


Business Insider Latest Story Image
3 mins read

Steroids can seriously reduce risk of death from COVID-19, new trials show. WHO is strongly recommending them.

Research published this week shows steroids may be the most effective drugs for serious cases of co…

Susie Neilson   


Business Insider Latest Story Image
2 mins read

How the pandemic is actually helping ALS research

Business Insider's biggest healthcare stories for August 24.

Lydia Ramsey Pflanzer   


Business Insider Latest Story Image
10 mins read

The 10 most promising coronavirus treatments that could help curb the pandemic, even without a vaccine

Most have entered human trials, and a few have already seen positive data — but some candidates hav…

Aria Bendix,Andrew Dunn   


Business Insider Latest Story Image
1 min read

COVID-19: Jubilant Life inks licensing agreement with Gilead for remdesivir

The EUA is based on available data from two global clinical trials -- US National Institute for Al…

PTI   


Business Insider Latest Story Image
7 mins read

People are paying as much as $10,000 for an unlicensed remdesivir variant for their cats, in a thriving black market linked to Facebook groups

A drug known as GS has brought hope to cat lovers, but also engendered an illegal drug trade for a …

Tom Porter   


Business Insider Latest Story Image
3 mins read

Hospitals are stuck waiting for supplies of a promising coronavirus treatment to arrive, days after health authorities OK'd its emergency use

Some hospitals are having a hard time getting remdesivir for their patients. The government is deci…

Lydia Ramsey,Andrew Dunn